GLP-1 weight-loss medications are seemingly taking over every conversation, including at the holiday dinner table
In fact, it may even act as a pro-oxidant in some cases
And consistency is where any wellness tool either becomes helpful or becomes clutter in a drawer
Mounjaro reduces abdominal fat indirectly by suppressing appetite and slowing gastric emptying, leading to sustained caloric deficit and overall fat loss, including visceral and subcutaneous fat around the abdomen, when combined with diet and exercise
How Wegovy and Topamax Work in the Body Understanding the distinct pharmacological actions of Wegovy and Topamax is crucial to appreciating why their combination requires clinical oversight
despite being taken as a daily pill rather than injection, it contains the same active ingredient and allegedly carries similar risks Mounjaro (tirzepatide): Manufactured by Eli Lilly and approved in May 2022, this medication works as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering enhanced blood sugar control and weight loss effects but also allegedly causing severe gastrointestinal injuries similar to semaglutide products Trulicity (dulaglutide): Eli Lillys once-weekly GLP-1 injection approved in 2014 for type 2 diabetes
